Get Patent Opposition Report for Galderma Holding

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Galderma Holding against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3079714Long Lasting Effect Of New Botulinum Toxin FormulationsMEDY TOXAug 24, 2021
EP2674147Hyaluronic Acid-Based Gels Including Anesthetic AgentsALLERGAN INDUSTRIESep 30, 2020